VAP RAPID

Trial Acronym	VAP Rapid-2
Clinical Area	Respiratory
Description	A randomised controlled trial of a biomarker based diagnosis of VAP to improve antibiotic stewardship.
Status	Closed

RECRUITMENT

Date Opened to Recruitment	01/09/2013
Target Recruitment	210
Recruitment to date	210
Date Closed to Recruitment	30/09/2016

TRIAL DESIGN

Trial Design	Multi-centre RCT
Study Aim	To determine whether a biomarker-based exclusion of VAP will result in less antibiotic use in patients with suspected VAP.

CHIEF INVESTIGATOR (CI)

Chief Investigator	Dr Thomas Hellyer
Principal Investigator	Professor John Simpson

SPONSORS & FUNDERS

Sponsor	Newcastle-upon-Tyne Hospitals NHS Trust
Funder	Wellcome Trust

REGISTRATION

NCT01972425

https://clinicaltrials.gov/ct2/show/NCT01972425